Menten AI Chooses Xanadu's Pennylane to Help Design Novel Drug Molecules

Menten AI is a biotech startup that is developing a software platform for protein design using next-generation technology that leverages machine learning and quantum computing. They have decided to use Xanadu's open-source PennyLane library as the base for its quantum machine learning solutions. Pennylane is a dedicated library for quantum machine learning that integrates many different simulators and quantum hardware platforms. It is a good fit for Menten's development approach of utilizing machine learning and quantum computing for drug design. Since both companies are located in Toronto, Canada, it may also make it a little easier for the two companies to work together. Additional information is available in a news release provided by Menten AI which is available here.

January 28, 2022